← Open Payments lookup

MOLLY DAVIS: Open Payments

NPI 1467114322 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,556 in 60 payments from 27 companies in 2025. Trend: 2023 $535 · 2024 $1,362 · 2025 $1,556

Food & beverage: $1,460Education: $96
CompanyPaymentsAmount
Gilead Sciences, Inc.4$160
Novartis Pharmaceuticals Corporation6$149
Janssen Biotech, Inc.5$130
Daiichi Sankyo Inc.4$111
ABBVIE INC.5$107
AstraZeneca Pharmaceuticals LP4$98
ARRAY BIOPHARMA INC4$96
Stemline Therapeutics Inc.3$82
Bayer Healthcare Pharmaceuticals Inc.2$58
Genentech USA, Inc.2$51

Products named: Trodelvy, Orserdu, PLUVICTO, Venclexta, Nubeqa, Enhertu, DATROWAY, XALKORI.

Industry payments across CO — which companies pay providers there.